{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:26:04Z","timestamp":1790832364405,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA100730"],"award-info":[{"award-number":["CA100730"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.coviro.2016.08.009","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T23:40:54Z","timestamp":1472859654000},"page":"40-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Human T-cell leukemia virus-associated malignancy"],"prefix":"10.1016","volume":"20","author":[{"given":"Amanda R","family":"Panfil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick L","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.08.009_bib0430","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1158\/0008-5472.CAN-05-0559","article-title":"Human T-cell leukemia virus type I at age 25: a progress report","volume":"65","author":"Matsuoka","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.coviro.2016.08.009_bib0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.1993.9.381","article-title":"An HTLV-I vaccine: why, how, for whom?","volume":"9","author":"DeThe","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.coviro.2016.08.009_bib0440","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0445","first-page":"21","article-title":"Seroepidemiology of the human retrovirus (HTLV\/ATLV) in Okinawa where adult T-cell leukemia is highly endemic","volume":"77","author":"Kohakura","year":"1986","journal-title":"Jpn J Cancer Res: Gann"},{"key":"10.1016\/j.coviro.2016.08.009_bib0450","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.2910400605","article-title":"Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based co-operative study in Tsushima, Japan","volume":"40","author":"Tajima","year":"1987","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2016.08.009_bib0455","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2016.08.009_bib0460","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.08.009_bib0465","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-07-2850","article-title":"Engagement of specific T cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes","author":"Barnard","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0470","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1128\/JVI.75.18.8461-8468.2001","article-title":"Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors","volume":"75","author":"Derse","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0475","doi-asserted-by":"crossref","first-page":"e1000788","DOI":"10.1371\/journal.ppat.1000788","article-title":"Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors","volume":"6","author":"Mazurov","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.coviro.2016.08.009_bib0480","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ijc.2910490508","article-title":"Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The Mother-to-Child Transmission Study Group","volume":"49","author":"Takahashi","year":"1991","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.coviro.2016.08.009_bib0485","first-page":"S68","article-title":"Intervention of maternal transmission of HTLV-1 in Nagasaki, Japan","volume":"8","author":"Hino","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.coviro.2016.08.009_bib0490","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/(SICI)1097-0215(19990909)82:6<832::AID-IJC11>3.0.CO;2-P","article-title":"Mother-to-child transmission of human T-cell-leukemia\/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers","volume":"82","author":"Ureta-Vidal","year":"1999","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.coviro.2016.08.009_sbref0495","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/jpids\/piu070","article-title":"Mother-to-child transmission of human T-cell lymphotropic viruses-1\/2: what we know, and what are the gaps in understanding and preventing this route of infection","volume":"3","author":"Carneiro-Proietti","year":"2014","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.coviro.2016.08.009_bib0500","doi-asserted-by":"crossref","first-page":"499","DOI":"10.14740\/jocmr2097w","article-title":"Prevalence of human T-cell leukemia virus type 1 carrier in Japanese pregnant women in 2013","volume":"7","author":"Suzuki","year":"2015","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.coviro.2016.08.009_bib0505","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4269\/ajtmh.2004.70.158","article-title":"A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan","volume":"70","author":"Kashiwagi","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.coviro.2016.08.009_bib0510","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00404-010-1559-1","article-title":"HTLV infection and its implication in gynaecology and obstetrics","volume":"282","author":"Mylonas","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.coviro.2016.08.009_bib0515","first-page":"1044","article-title":"Search for possible routes of vertical and horizontal transmission of adult T-cell leukemia virus","volume":"75","author":"Nakano","year":"1984","journal-title":"Gann"},{"key":"10.1016\/j.coviro.2016.08.009_bib0520","first-page":"893","article-title":"Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus","volume":"73","author":"Tajima","year":"1982","journal-title":"Gann"},{"key":"10.1016\/j.coviro.2016.08.009_bib0525","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-111-7-555","article-title":"Sexual transmission of human T-lymphotropic virus type I (HTLV-I)","volume":"111","author":"Murphy","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coviro.2016.08.009_bib0530","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00042560-199606010-00014","article-title":"Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group","volume":"12","author":"Kaplan","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0535","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1086\/429410","article-title":"A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II","volume":"191","author":"Roucoux","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.08.009_bib0540","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/infdis\/154.5.851","article-title":"Intrafamilial transmission of adult T cell leukemia virus","volume":"154","author":"Kajiyama","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.08.009_bib0545","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/archinte.1991.00400100115019","article-title":"Transmission of human T-lymphotropic virus types I and II by blood transfusion: a retrospective study of recipients of blood components","volume":"151","author":"Sullivan","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.coviro.2016.08.009_bib0550","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1423-0410.1984.tb00083.x","article-title":"A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients","volume":"46","author":"Okochi","year":"1984","journal-title":"Vox Sang"},{"key":"10.1016\/j.coviro.2016.08.009_bib0555","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ijc.2910510609","article-title":"A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion","volume":"51","author":"Manns","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coviro.2016.08.009_sbref0560","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/cid\/ciu227","article-title":"Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002\u20132012","volume":"59","author":"Hewagama","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2016.08.009_bib0565","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V76.8.1657.1657","article-title":"Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits","volume":"76","author":"Kataoka","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0570","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1128\/JVI.02752-06","article-title":"Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses","volume":"81","author":"Derse","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0575","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coviro.2016.08.009_bib0580","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1742-4690-6-71","article-title":"The HBZ gene, a key player in HTLV-1 pathogenesis","volume":"6","author":"Matsuoka","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2016.08.009_bib0585","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/meth.1998.0646","article-title":"Regulation of gene expression by HTLV-I Tax protein","volume":"16","author":"Bex","year":"1998","journal-title":"Methods"},{"key":"10.1016\/j.coviro.2016.08.009_bib0590","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","article-title":"Molecular mechanisms of cellular transformation by HTLV-1 Tax","volume":"24","author":"Grassmann","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2016.08.009_sbref0595","doi-asserted-by":"crossref","DOI":"10.3390\/v8060161","article-title":"HTLV-1 infection and adult T-cell leukemia\/lymphoma-A tale of two proteins: tax and HBZ","volume":"8","author":"Giam","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2016.08.009_sbref0600","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.08.009_bib0605","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.08.009_bib0610","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1182\/blood-2005-11-4551","article-title":"Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1","volume":"107","author":"Arnold","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0615","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","article-title":"Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T lymphocyte proliferation","volume":"112","author":"Arnold","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0620","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0625","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.08.009_sbref0630","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia\u2013lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0635","doi-asserted-by":"crossref","first-page":"5","DOI":"10.13055\/ojhmt_5_1_5.140623","article-title":"Mogamulizumab for adult T-cell leukemia\/lymphoma expressing atypical phenotype CD4\u2212\/CD8+\/CCR4+","volume":"5","author":"Ureshino","year":"2014","journal-title":"Open J Hematol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0640","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia\u2013lymphoma. A report from the lymphoma study group (1984\u20131987)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0645","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.coviro.2016.08.009_bib0650","first-page":"431","article-title":"Detection of preleukemic state of adult T-cell leukemia (pre-ATL) in HTLV-1 carriers","volume":"14","author":"Ikeda","year":"1990","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.coviro.2016.08.009_bib0655","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","article-title":"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study","volume":"61","author":"Orland","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.coviro.2016.08.009_bib0660","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Goncalves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coviro.2016.08.009_bib0665","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/sj.onc.1208970","article-title":"Cellular immune response to HTLV-1","volume":"24","author":"Bangham","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2016.08.009_bib0670","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fmicb.2012.00270","article-title":"HTLV-1 uveitis","volume":"3","author":"Kamoi","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0675","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/exd.12007","article-title":"HTLV-1-associated infective dermatitis: updates on the pathogenesis","volume":"21","author":"McGill","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0680","first-page":"761","article-title":"High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy\/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1","volume":"42","author":"Primo","year":"2009","journal-title":"Braz J Med Biol Res, Rev Bras Pesq Med Biol\/Soc Brasil Biofis \u2026 [et al.]"},{"key":"10.1016\/j.coviro.2016.08.009_bib0685","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0690","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2005.05.010","article-title":"HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM\/TSP patients: a marker of disease progression","volume":"237","author":"Olindo","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.coviro.2016.08.009_bib0695","doi-asserted-by":"crossref","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","article-title":"Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy","volume":"8","author":"Tattermusch","year":"2012","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.coviro.2016.08.009_bib0700","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0705","series-title":"WHO Classification of Tumours; Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"200","article-title":"Adult T-cell leukaemia\/lymphoma","author":"Kikuchi","year":"2001"},{"key":"10.1016\/j.coviro.2016.08.009_sbref0710","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2014-02-553602","article-title":"The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia\/lymphoma","volume":"123","author":"Cook","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0715","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","article-title":"Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease","volume":"89","author":"Tsukasaki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0720","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.leukres.2006.11.013","article-title":"Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia\/lymphoma (ATLL)","volume":"31","author":"Takasaki","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.coviro.2016.08.009_bib0725","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0730","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/1097-0142(19880215)61:4<824::AID-CNCR2820610430>3.0.CO;2-6","article-title":"Adult T-cell leukemia with leukemia cell infiltration into the gastrointestinal tract","volume":"61","author":"Utsunomiya","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.coviro.2016.08.009_bib0735","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood.V97.12.3875","article-title":"Comparative genomic hybridization analysis in adult T-cell leukemia\/lymphoma: correlation with clinical course","volume":"97","author":"Tsukasaki","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0740","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1182\/blood.V97.11.3612","article-title":"Cytogenetic analysis and clinical significance in adult T-cell leukemia\/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki","volume":"97","author":"Itoyama","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0745","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2005.03.039","article-title":"Impact of p53 aberration on the progression of Adult T-cell Leukemia\/Lymphoma","volume":"234","author":"Tawara","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.coviro.2016.08.009_bib0750","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","article-title":"IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0755","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-4690-10-52","article-title":"Interferon-alpha (IFN-alpha) suppresses HTLV-1 gene expression and cell cycling, while IFN-alpha combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells","volume":"10","author":"Kinpara","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2016.08.009_bib0760","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia\u2013lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0765","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia\u2013lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0770","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia\u2013lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coviro.2016.08.009_sbref0775","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1038\/bcj.2016.21","article-title":"Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma","volume":"6","author":"Ratner","year":"2016","journal-title":"Blood cancer journal"},{"key":"10.1016\/j.coviro.2016.08.009_bib0780","doi-asserted-by":"crossref","first-page":"e4420","DOI":"10.1371\/journal.pone.0004420","article-title":"Human T cell leukemia virus reactivation with progression of adult T-cell leukemia\u2013lymphoma","volume":"4","author":"Ratner","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2016.08.009_bib0785","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia\u2013lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.08.009_bib0790","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia\u2013lymphoma with zidovudine and interferon alfa","volume":"332","author":"Hermine","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.08.009_bib0795","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428190109057927","article-title":"The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia\/lymphoma","volume":"40","author":"White","year":"2001","journal-title":"Leukemia & lymphoma"},{"key":"10.1016\/j.coviro.2016.08.009_bib0800","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0805","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.coviro.2016.08.009_bib0810","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_sbref0815","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.bbmt.2014.12.020","article-title":"A retrospective analysis of treatment outcomes in adult T cell leukemia\/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: a single-center experience","volume":"21","author":"Kawada","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.coviro.2016.08.009_bib0820","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/aid.1996.12.403","article-title":"Vaccine against human T cell leukemia\u2013lymphoma virus type I: progress and prospects","volume":"12","author":"Bomford","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.coviro.2016.08.009_bib0825","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/v3071210","article-title":"Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV","volume":"3","author":"Rodriguez","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2016.08.009_bib0830","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.13302","article-title":"Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia\/lymphoma in a pilot study","volume":"169","author":"Suehiro","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.coviro.2016.08.009_bib0835","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2015-04-641118","article-title":"Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor","volume":"126","author":"Sugata","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.coviro.2016.08.009_bib0840","first-page":"49","article-title":"Animal models utilized in HTLV-1 research","volume":"4","author":"Panfil","year":"2013","journal-title":"Virol: Res Treat"},{"key":"10.1016\/j.coviro.2016.08.009_bib0845","doi-asserted-by":"crossref","first-page":"e1002231","DOI":"10.1371\/journal.ppat.1002231","article-title":"HTLV-1 propels thymic human T cell development in \u201chuman immune system\u201d Rag2(\u2212)\/(\u2212) gamma c(\u2212)\/(\u2212) mice","volume":"7","author":"Villaudy","year":"2011","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.coviro.2016.08.009_bib0850","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4939-1133-2_18","article-title":"Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development","volume":"1185","author":"Aryee","year":"2014","journal-title":"Methods Mol Biol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T19:08:47Z","timestamp":1601060927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716301055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":85,"alternative-id":["S1879625716301055"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.08.009","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human T-cell leukemia virus-associated malignancy","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}